Very Low LDL-C Targets in Ischemic Stroke: Reframing Secondary Prevention in the PCSK9 Era. Diabzen, [S. l.], v. 3, n. 3, p. 67–71, 2025. Disponível em: https://thediabzen.com/index.php/d/article/view/22. Acesso em: 14 apr. 2026.